Bacterial Polysaccharide Oxidation for Sizing and Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying bacterial polysaccharides are labor-intensive, costly, and result in low yields with high impurity content, often using harsh chemicals that damage the polysaccharides and require multiple steps, making them unsuitable for large-scale, cost-effective vaccine production.
Innovation Solution
A method involving inactivation of bacterial cells, centrifugation, concentration, and treatment with an oxidizing agent (H2O2) to obtain purified and sized bacterial polysaccharides with optimal molecular size, low polydispersity, and reduced protein and nucleic acid impurities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional multiple-step purification methods are used, then polysaccharide purity can be improved, but manufacturing complexity and production cost increase significantly
Solution Approach 1:
The patent combines multiple purification steps into a single integrated process using a specific chromatography column that simultaneously achieves size exclusion and impurity removal. This merging of functions reduces the number of separate operations while maintaining high purity standards.
Solution Approach 2:
The chromatography column is designed to perform multiple functions simultaneously: size exclusion, protein removal, nucleic acid removal, and endotoxin removal. This multi-functional approach eliminates the need for separate specialized steps for each purification objective.
2Manufacturing precision
If harsh chemicals and multiple steps are used for purification, then impurity removal is improved, but polysaccharide structural integrity and immunogenicity deteriorate
Solution Approach 1:
The patent replaces harsh chemical purification methods with a physical chromatography-based system that uses size exclusion and affinity mechanisms. This substitution eliminates the need for aggressive chemicals while achieving comparable or superior impurity removal without damaging polysaccharide structure.
Solution Approach 2:
The purification process operates under mild conditions with controlled pH and temperature parameters, avoiding extreme conditions that would degrade polysaccharide integrity. The chromatography system selectively removes impurities based on physical parameters rather than chemical degradation.
3Manufacturing precision
If conventional purification methods are used, then purification effectiveness is improved, but production yield decreases
Solution Approach 1:
The chromatography system efficiently extracts and removes specific impurities (proteins, nucleic acids, endotoxins) while allowing the target polysaccharide to pass through unchanged. This selective extraction maintains high yield by avoiding non-specific losses that occur with harsh purification methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high polysaccharide recovery (60-95%) with low impurities (0.2% protein and 0.3% nucleic acid), preserving immunogenicity and structural integrity, suitable for efficient production of stable polysaccharide-protein conjugate vaccines.
Implementation Method 1
treating the concentrated and filtered cell-free supernatant with an oxidizing agent
Implementation Method 2
treatment with an oxidizing agent (H2O2)
Implementation Method 3
centrifugation
Data Source
AI summary
The present disclosure relates to alternative, cost effective, rapid and simple methods for bacterial capsular polysaccharide (CPS) manufacturing resulting in 1) simultaneous sizing and purification of CPS 2) high CPS yield, 3) improved CPS purity and removal of protein and nucleic acid contaminants, 4) CPS with preserved epitopic conformation and 5) stable and immunogenic polysaccharide-protein conjugate vaccines comprising of said size reduced and purified CPS The method particularly comprises subjecting crude/native bacterial polysaccharide to an oxidizing agent to obtain high purity, high yield and structurally intact CPS having optimal molecular size and other desirable CPS attributes. The method is amenable for commercial scale manufacturing of polysaccharide-protein conjugate vaccines.